Antiviral activity of influenza virus M1 zinc finger peptides

Journal of Virology

Volumn 70, Issue 12, 1996, Pages 8639-8644

  Nasser, Ezzeldin H ^a   Judd, Amrit K ^b   Sanchez, Agustin ^c   Anastasiou, Dimitrios ^a   Bucher, Doris J ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b SRI INTERNATIONAL   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; MATRIX PROTEIN; RIBAVIRIN; SYNTHETIC PEPTIDE; ZINC FINGER PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; INFLUENZA VIRUS; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; VIRUS ASSEMBLY; VIRUS INHIBITION; VIRUS TRANSCRIPTION;

EID: 0029914173     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.12.8639-8644.1996     Document Type: Article

References (28)

1. Advisory Committee on Immunization Practices (ACIP). 1992. Prevention and control of influenza. Morbid. Mortal. Weekly Rep. 41(no. RR-9):1-16.
2. Allen, H., J. McCauley, M. Waterfield, and M. J. Getbing. 1980. Influenza virus RNA segment 7 has the coding capacity tor two polypeptides. Virology 107:548-551.
3. Bucher, D., S. Popple, M. Baer, A. Mikhail, Y. Gong, C. Whitaker, E. Paoletti, and A. Judd. 1989. M protein (M1) of influenza virus: antigenic analysis and intracellular localization with monoclonal antihodies. J. Virol. 63:3622-3531
4. Calnan, J. B., B. Tidor, S. Biancalana, D. Hudson, and A. D. Frankal. 1991. Argininc-mediated RNA recognition: the arginine fork. Science 252:1167-1171.
5. Dannull, J., A. Surovoy, G. Jung, and K. Moelling. 1994. Specific binding of HIV-1 nucleocapsid protein to psi RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues. EMBO J. 13:1525-1533.
6. Elster, C. E. Fourest, F. Baudin, K. Larsen, S. Cusak, and W. H. Ruigrok. 1994. A small percentage of influenza virus M1 protein contains zinc but does not influence in vitro M1-RNA interaction. J. Gen. Virol. 75:37-42.
7. Erickson, W. B., and R. B. Merrifield. 1976. Solid phase peptide synthesis, p. 255-527. In H. Neurath and R. L. Hill (ed.), The proteins, vol. II. Academic Press, Inc., New York.
8. Evans, M. R., and S. M. Hollenberg. 1988. Zinc finger: gift by association. Cell 52:1-3.
9. Gorelick, R. J., L. E. Henderson, J. P. Hanser, and A. Rein. 1988. Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a 'zinc finger like' protein sequence. Proc. Natl. Acad. Sci. USA 85:8420-8424.
10. Hankins, W. R., K. Nagata, D. J. Bucher, S. Popple, and A. Ishihama. 1989. Monoclonal antibody analysis of influenza virus matrix protein epitopes involved in transcription inhibition. Virus Genes 3:111-126.
11. Ito, T., O. T. Gorman, Y. Kawaoka, W. J. Bean, and R. G. Webster. 1991. Evolutionary analysis of the influenza A virus M gene with comparison of M1 and M2 proteins. J. Virol. 65:5491-5498.
12. Judd, A. K., E. Nasser, and D. Bucher, 1992. Zinc-binding properties of a peptide from matrix (M1) protein of influenza virus, Options for the Control of Influenza II. Abstr., p. 87. Courchevel. France.
13. Judd, A. K., A. Sanchez, I. Kharitonenkov, A. Moscona, E. Nasser, and D. Bucher. 1992. M-protein peptides of influenza virus: application as antiviral agents, p. 694-696. In J. A. Smith and J. Rivier (ed.), Peptides, chemistry and biology. Escom. Leiden, The Netherlands.
14. Judd, A. K., A. Sanchez, D. J. Bucher, J. H. Huffman, K. Bailey, and R. W. Sidwell. Submitted for publication.
15. Klug, A., and D. Rhodes. 1987. Zinc fingers: a novel protein motif for nucleicacid recognition. Trends Biochem. Sci. 12:464-470.
16. Komatsu, H., and H. Tozawa. 1994. Viral RNA-binding activity of HIV-2 nucleocapsid protein is inhibited by a synthetic peptide containing the first zinc finger motif of HIV-2. AIDS 8:1227-1235.
17. Lamb, R. A., and C. J. Lai. 1981. Conservation of the influenza virus membrane protein (M1) amino acid sequence and an open reading frame of RNA segment 7 encoding a second protein (M2) in H1N1 and H3N2 strains. Virology 112:746-751.
18. Mast, E. E., M. W. Harmon, S. Gravenstein, S. P. Wu, N. H. Arden, R. Circo, G. Tyszka, A. P. Kendal, and J. P. Davis. 1991. Emergence and possibletransmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2). Am. J. Epidemiol. 134:988-997.
19. phc binding: a steady-stale and time-resolved fluorescence study. Biophys. J. 65:1513-1522.
20. Miller, J., A. D. Mclachlan, and A. Klug. 1985. Repetitive zinc-binding domains in the protein transcriplion factor IIIA from Xenopus oocytes. EMBO J. 4:1609-1614.
21. Smith, R. D., I. J. Jackson, and D. D. Brown. 1984. Domains of the positive transcription factor specific for the Xenopus 5S RNA gene. Cell 37:645-652.
22. Wakefield, L., and G. G. Brownlee, 1988. RNA-binding activity of the influenza virus matrix protein. Virus Res. 2(Suppl.):35.
23. Wakefield, L., and G. G. Brownlee, 1989. RNA-binding properties of influenza A virus matrix protein M1. Nucleic Acids Res. 17:8569-8580.
24. Winter, G., and S. Fields. 1980. Cloning of influenza cDNA into M13: the sequence of the RNA segment encoding the A/PR/8/34 matrix protein. Nucleic Acids Res. 8:1965-1974.
25. Ye, Z., W. Baylor, and R. R. Wagner. 1989. Transcription inhibition and RNA binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides. J. Virol. 63:3586-3594.
26. Ye, Z., R. Pal, J. W. Fox, and R. R. Wagner. 1987. Functional and antigenic domains of the matrix (M1) protein of the influenza virus. J. Virol. 61:239-245.
27. Ye, Z., and R. R. Wagner. 1992. Down regulation of vesicular stomatitis virus transcription by the matrix protein of influenza virus. J. Gen. Virol. 73:743-748.
28. Zvonarjev, A. Y., and Y. Z. Ghendon. 1980. Influence of membrane (M) protein on influenza A virus virion transcriptase activity in vitro and its susceptibility to rimantadinc. J. Virol. 33:583-586.